Poland· PL-100473084
Ketorolac trometamol Misom
A ketorolac product containing ketorolacum trometamolum, registered in Poland by Brown & Burk IR Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ketorolac is registered in 12 of 19 countries.
Countries holding a registration under ATC S01BC05 (ketorolac), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Ketorolac · ATC S01BC05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketorolac costs, country by country.
Normalised to the WHO defined daily dose (0.75 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketorolac · price per daily dose (0.75 mg)
USD · FX 28 Sept 2026
- US United States$0.012 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Ketorolacum trometamolum
- Manufacturer
- Brown & Burk IR Ltd
- Country
- Poland (PL)
- ATC code
- S01BC05
- ATC class
- Ketorolac
- Defined daily dose
- 0.75 mg, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991580810
- gtin05909991580827
- gtin05909991580834
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for ketorolac.
Graded by severity as the source publishes them — 81 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketorolac · interactions on record
81 records
- 81 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01BC05
Ketorolac, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce7dd100-3aca-4dd1-a198-f370dbbdd682 GET /v1/drugs/ce7dd100-3aca-4dd1-a198-f370dbbdd682?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "05909991580810 ¦ Rp ¦ 162960\n1 poj. 5 ml\n05909991580827 ¦ Rp ¦ 162961\n3 poj. 5 ml\n05909991580834 ¦ Rp ¦ 162962\n1 poj. 10 ml",
"substance": "Ketorolacum trometamolum 5 mg/ml",
"common_name": "Ketorolacum trometamolum",
"pl_product_id": "100473084",
"pozwolenie_nr": "29191",
"auth_procedure": "DCP",
"authorisation_validity": "2030-07-16"
}See everything about ketorolac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.